Abstract:Mass spectrometry imaging (MSI) provides insight into the molecular distribution of a broad range of compounds and, therefore, is frequently applied in the pharmaceutical industry. Pharmacokinetic and toxicological studies deploy MSI to localize potential drugs and their metabolites in biological tissues but currently require other analytical tools to quantify these pharmaceutical compounds in the same tissues. Quantitative mass spectrometry imaging (Q-MSI) is a field with challenges due to the high biological variability in samples combined with the limited sample cleanup and separation strategies available prior to MSI. In consequence, more selectivity in MSI instruments is required. This can be provided by multiple reaction monitoring (MRM) which uses specific precursor ion-product ion transitions. This targeted approach is in particular suitable for pharmaceutical compounds because their molecular identity is known prior to analysis. In this work, we compared different analytical platforms to assess the performance of MRM detection compared to other MS instruments/MS modes used in a Q-MSI workflow for two drug candidates (A and B). Limit of detection (LOD), linearity, and precision and accuracy of high and low quality control (QC) samples were compared between MS instruments/modes. MRM mode on a triple quadrupole mass spectrometer (QqQ) provided the best overall performance with the following results for compounds A and B: LOD 35.5 and 2.5 μg/g tissue, R2 0.97 and 0.98 linearity, relative standard deviation QC <13.6%, and 97-112% accuracy. Other MS modes resulted in LOD 6.7-569.4 and 2.6-119.1 μg/g tissue, R2 0.86-0.98 and 0.86-0.98 linearity, relative standard deviation QC < 19.4 and < 37.5%, and 70-356% and 64-398% accuracy for drug candidates A and B, respectively. In addition, we propose an optimized 3D printed mimetic tissue model to increase the overall analytical throughput of our approach for large animal studies. The MRM imaging platform was applied as proof-of-principle for quantitative detection of drug candidates A and B in four dog livers and compared to LC-MS. The Q-MSI concentrations differed <3.5 times with the concentrations observed by LC-MS. Our presented MRM-based Q-MSI approach provides a more selective and high-throughput analytical platform due to MRM specificity combined with an optimized 3D printed mimetic tissue model.

Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Mass Spectrometry Imaging: Applications in Drug Distribution Studies

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery

Mass Spectrometry Imaging and Its Application in Biomedical Fields

MALDI Mass Spectrometry Imaging in Targeted Drug Discovery and Development: the Pros, the Cons, and Prospects in Global Omics Techniques

Recent advancement and applications of mass spectrometry imaging

A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry

Development of mass spectrometry imaging techniques and its latest applications

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Emerging Technologies in Mass Spectrometry Imaging

A vision for better health: mass spectrometry imaging for clinical diagnostics.

Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison

Mass Spectrometry Imaging for Biomedical Applications

Advances in mass spectrometry imaging for toxicological analysis and safety evaluation of pharmaceuticals

Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development

Mass spectrometry imaging: new eyes on natural products for drug research and development

Targeted Desorption Electrospray Ionization Mass Spectrometry Imaging for Drug Distribution, Toxicity, and Tissue Classification Studies

Spatial pharmacology using mass spectrometry imaging